Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1
https://doi.org/10.18632/oncotarget.2529 Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar, Anthony D. Ho, Hartmut Goldschmidt, Alwin...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 26, 2014
|
| In: |
OncoTarget
Year: 2014, Volume: 5, Issue: 21, Pages: 10237-10250 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.2529 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.18632/oncotarget.2529 Verlag, lizenzpflichtig, Volltext: https://www.oncotarget.com/article/2529/text/ 
|
| Author Notes: | Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar, Anthony D. Ho, Hartmut Goldschmidt, Alwin Krämer, Bernard Klein and Marc S. Raab |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1725691760 | ||
| 003 | DE-627 | ||
| 005 | 20220818162829.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200728s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.2529 |2 doi | |
| 035 | |a (DE-627)1725691760 | ||
| 035 | |a (DE-599)KXP1725691760 | ||
| 035 | |a (OCoLC)1341348753 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wagner, Verena |d 1987- |e VerfasserIn |0 (DE-588)1106414608 |0 (DE-627)863140599 |0 (DE-576)474107531 |4 aut | |
| 245 | 1 | 0 | |a Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 |c Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar, Anthony D. Ho, Hartmut Goldschmidt, Alwin Krämer, Bernard Klein and Marc S. Raab |
| 264 | 1 | |c September 26, 2014 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.07.2020 | ||
| 520 | |a https://doi.org/10.18632/oncotarget.2529 Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar, Anthony D. Ho, Hartmut Goldschmidt, Alwin... | ||
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Seckinger, Anja |d 1980- |e VerfasserIn |0 (DE-588)134177371 |0 (DE-627)562118225 |0 (DE-576)278603734 |4 aut | |
| 700 | 1 | |a Weiz, Ludmila |e VerfasserIn |0 (DE-588)1049395646 |0 (DE-627)781858631 |0 (DE-576)403364485 |4 aut | |
| 700 | 1 | |a Meißner, Tobias |e VerfasserIn |0 (DE-588)1014101379 |0 (DE-627)705167224 |0 (DE-576)348311613 |4 aut | |
| 700 | 1 | |a Breitkreutz, Iris |d 1970- |e VerfasserIn |0 (DE-588)124783309 |0 (DE-627)366051806 |0 (DE-576)186798725 |4 aut | |
| 700 | 1 | |a Podar, Klaus |e VerfasserIn |0 (DE-588)1058672169 |0 (DE-627)797396594 |0 (DE-576)414826795 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 5(2014), 21, Seite 10237-10250 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 |
| 773 | 1 | 8 | |g volume:5 |g year:2014 |g number:21 |g pages:10237-10250 |g extent:14 |a Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 |
| 856 | 4 | 0 | |u https://doi.org/10.18632/oncotarget.2529 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.oncotarget.com/article/2529/text/ |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200728 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 13 |y j | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |d 910000 |d 910100 |e 910000PK1067780025 |e 910100PK1067780025 |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ | ||
| 998 | |g 1058672169 |a Podar, Klaus |m 1058672169:Podar, Klaus |d 910000 |d 910100 |e 910000PP1058672169 |e 910100PP1058672169 |k 0/910000/ |k 1/910000/910100/ | ||
| 998 | |g 124783309 |a Breitkreutz, Iris |m 124783309:Breitkreutz, Iris |d 910000 |d 910100 |e 910000PB124783309 |e 910100PB124783309 |k 0/910000/ |k 1/910000/910100/ | ||
| 998 | |g 1014101379 |a Meißner, Tobias |m 1014101379:Meißner, Tobias | ||
| 998 | |g 1049395646 |a Weiz, Ludmila |m 1049395646:Weiz, Ludmila | ||
| 998 | |g 134177371 |a Seckinger, Anja |m 134177371:Seckinger, Anja |d 910000 |d 910100 |e 910000PS134177371 |e 910100PS134177371 |k 0/910000/ |k 1/910000/910100/ | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |d 50000 |e 910000PH139824995 |e 910100PH139824995 |e 50000PH139824995 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 | ||
| 998 | |g 1106414608 |a Wagner, Verena |m 1106414608:Wagner, Verena |d 50000 |e 50000PW1106414608 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1725691760 |e 3730990985 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"14 S."}],"id":{"eki":["1725691760"],"doi":["10.18632/oncotarget.2529"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 28.07.2020"],"relHost":[{"language":["eng"],"recId":"63035975X","disp":"Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1OncoTarget","pubHistory":["1.2010,Mai -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"OncoTarget","title_sort":"OncoTarget","subtitle":"open access impact journal"}],"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010","dateIssuedDisp":"2010-","publisher":"Impact Journals LLC"}],"note":["Gesehen am 16.08.2018"],"id":{"eki":["63035975X"],"zdb":["2560162-3"],"issn":["1949-2553"]},"part":{"pages":"10237-10250","year":"2014","text":"5(2014), 21, Seite 10237-10250","volume":"5","issue":"21","extent":"14"},"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"role":"aut","family":"Wagner","given":"Verena","display":"Wagner, Verena"},{"role":"aut","family":"Hose","given":"Dirk","display":"Hose, Dirk"},{"role":"aut","family":"Seckinger","given":"Anja","display":"Seckinger, Anja"},{"role":"aut","family":"Weiz","display":"Weiz, Ludmila","given":"Ludmila"},{"given":"Tobias","display":"Meißner, Tobias","family":"Meißner","role":"aut"},{"family":"Breitkreutz","given":"Iris","display":"Breitkreutz, Iris","role":"aut"},{"role":"aut","given":"Klaus","display":"Podar, Klaus","family":"Podar"},{"role":"aut","given":"Anthony Dick","display":"Ho, Anthony Dick","family":"Ho"},{"role":"aut","family":"Goldschmidt","given":"Hartmut","display":"Goldschmidt, Hartmut"},{"role":"aut","given":"Alwin","display":"Krämer, Alwin","family":"Krämer"},{"role":"aut","display":"Raab, Marc-Steffen","given":"Marc-Steffen","family":"Raab"}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"September 26, 2014"}],"name":{"displayForm":["Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar, Anthony D. Ho, Hartmut Goldschmidt, Alwin Krämer, Bernard Klein and Marc S. Raab"]},"recId":"1725691760","title":[{"title_sort":"Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1","title":"Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1"}],"language":["eng"]} | ||
| SRT | |a WAGNERVEREPRECLINICA2620 | ||